1.95
前日終値:
$1.93
開ける:
$1.93
24時間の取引高:
842.41K
Relative Volume:
0.27
時価総額:
$110.88M
収益:
-
当期純損益:
$-82.44M
株価収益率:
-1.0372
EPS:
-1.88
ネットキャッシュフロー:
$-66.75M
1週間 パフォーマンス:
+18.90%
1か月 パフォーマンス:
+43.38%
6か月 パフォーマンス:
-25.57%
1年 パフォーマンス:
-62.79%
Black Diamond Therapeutics Inc Stock (BDTX) Company Profile
名前
Black Diamond Therapeutics Inc
セクター
電話
617-417-5868
住所
ONE MAIN STREET, 14TH FLOOR, CAMBRIDGE, MA
BDTX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
BDTX
Black Diamond Therapeutics Inc
|
1.95 | 92.95M | 0 | -82.44M | -66.75M | -1.88 |
![]()
ONC
Beigene Ltd Adr
|
228.38 | 25.07B | 3.81B | -644.79M | -669.77M | -6.24 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
438.65 | 109.14B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
AKTX
Akari Therapeutics Plc Adr
|
1.27 | 36.39M | 0 | 0 | 0 | 0.00 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
594.32 | 56.98B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
VRNA
Verona Pharma Plc Adr
|
71.31 | 5.39B | 0 | -153.72M | -103.81M | -2.00 |
Black Diamond Therapeutics Inc Stock (BDTX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-07-31 | 開始されました | Raymond James | Outperform |
2023-07-14 | 開始されました | Piper Sandler | Overweight |
2023-06-30 | アップグレード | Stifel | Hold → Buy |
2023-06-28 | アップグレード | H.C. Wainwright | Neutral → Buy |
2023-06-27 | アップグレード | Wedbush | Neutral → Outperform |
2022-03-29 | ダウングレード | Wedbush | Outperform → Neutral |
2022-03-22 | ダウングレード | H.C. Wainwright | Buy → Neutral |
2021-09-30 | 開始されました | Stifel | Hold |
2021-01-07 | 開始されました | Wedbush | Outperform |
2020-11-24 | 開始されました | Berenberg | Buy |
2020-05-04 | 開始されました | H.C. Wainwright | Buy |
2020-02-24 | 開始されました | Canaccord Genuity | Buy |
2020-02-24 | 開始されました | Cowen | Outperform |
2020-02-24 | 開始されました | JP Morgan | Overweight |
2020-02-24 | 開始されました | Jefferies | Buy |
すべてを表示
Black Diamond Therapeutics Inc (BDTX) 最新ニュース
Wedbush Issues Optimistic Estimate for BDTX Earnings - Defense World
Raymond James Financial Inc. Makes New Investment in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Stifel Financial Corp Raises Stock Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Wells Fargo & Company MN Buys 5,932 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Black Diamond Therapeutics Inc (BDTX) Q1 2025 Earnings: Net Inco - GuruFocus
Black Diamond (BDTX) Strengthens Financial Position with Robust Cash Reserves | BDTX Stock News - GuruFocus
Black Diamond Therapeutics (BDTX) Surpasses Q1 Earnings Expectat - GuruFocus
What You Didn’t Know About Black Diamond Therapeutics Inc (NASDAQ: BDTX) This Week - Stocksregister
Hsbc Holdings PLC Has $59,000 Holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Barclays PLC Increases Stock Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Black Diamond Therapeutics Reports Q1 2025 Financial Results and Updates on Clinical Trials for BDTX-1535 - Nasdaq
Black Diamond Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Skill-Knowledge-Conduct - TradingView
JPMorgan Chase & Co. Has $41,000 Holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Market Momentum: Black Diamond Therapeutics Inc (BDTX) Registers a -12.28 Decrease, Closing at 1.47 - DWinneX
BlackRock, Inc. Reduces Stake in Black Diamond Therapeutics Inc - GuruFocus
Black Diamond Therapeutics Inc expected to post earnings of 20 cents a shareEarnings Preview - TradingView
Positive week for Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) institutional investors who lost 74% over the past year - Yahoo Finance
A History of Outperforming Analyst Forecasts and Beating the Odds: Black Diamond Therapeutics Inc (BDTX) - Sete News
Black Diamond Therapeutics Inc (BDTX) stock analysis: A comprehensive overview - uspostnews.com
Black Diamond Therapeutics Inc’s Banking’s 100-Day Moving Average at 2.0161: Will the Stock Break Through? - investchronicle.com
Geode Capital Management LLC Has $2.05 Million Holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Financial Metrics Exploration: Understanding Black Diamond Therapeutics Inc (BDTX) Through Ratios - DWinneX
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Bought by Renaissance Technologies LLC - The AM Reporter
Black Diamond Therapeutics Inc (BDTX) presents a great opportunity, but the stock is slightly overvalued - uspostnews.com
Head-To-Head Contrast: Avalon GloboCare (NASDAQ:ALBT) and Black Diamond Therapeutics (NASDAQ:BDTX) - Defense World
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Acquired by Wellington Management Group LLP - Defense World
Raymond James Financial Inc. Purchases New Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Sei Investments Co. Purchases Shares of 22,802 Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
BDTX Stock Sees Decline of Approximately -12.66% in Last Five Days - knoxdaily.com
Black Diamond stock hits 52-week low at $1.42 amid challenges - Investing.com India
Black Diamond stock hits 52-week low at $1.42 amid challenges By Investing.com - Investing.com South Africa
Black Diamond Therapeutics Inc [BDTX] stock for 11,997,749 USD was sold by BIOTECH GROWTH N V - knoxdaily.com
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Stock Holdings Raised by Intech Investment Management LLC - The AM Reporter
Bank of New York Mellon Corp Purchases 65,341 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Black Diamond Therapeutics’ Global Licensing Deal with Servier - Global Legal Chronicle
BDTX stock touches 52-week low at $1.59 amid market challenges - Investing.com Australia
Black Diamond Therapeutics Trades Well Below Cash After Lucrative Deal With Servier - Seeking Alpha
What is Wedbush’s Estimate for BDTX Q1 Earnings? - Defense World
Connor Clark & Lunn Investment Management Ltd. Sells 37,472 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
BB Biotech AG Reduces Stake in Black Diamond Therapeutics Inc - GuruFocus
Black Diamond Therapeutic Stock Price, Quotes and Forecasts | NASDAQ:BDTX - Benzinga
Stock Traders Buy High Volume of Call Options on Black Diamond Therapeutics (NASDAQ:BDTX) - Defense World
Black Diamond Therapeutics sees $11.99m stock sale by BB Biotech AG - Investing.com India
Growth Stocks To Add to Your Watchlist – March 19th - Defense World
Black Diamond Therapeutics (NASDAQ:BDTX) Earns “Outperform” Rating from Wedbush - Defense World
HC Wainwright Has Bearish Forecast for BDTX Q1 Earnings - Defense World
Growth Stocks To Add to Your WatchlistMarch 19th - MarketBeat
Black Diamond Therapeutics Surge: Savvy Move or Bubble? - timothysykes.com
Black Diamond Therapeutics Inc (BDTX) 財務データ
収益
当期純利益
現金流量
EPS
Black Diamond Therapeutics Inc (BDTX) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Versant Venture Capital VI, L. | 10% Owner |
Aug 28 '24 |
Sale |
6.32 |
221,600 |
1,400,556 |
3,726,341 |
大文字化:
|
ボリューム (24 時間):